Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
As US-based streaming platforms chase audiences around the world, they’re increasingly committing to international productions.
On Wednesday, Bloomberg reported that one billion people are watching podcasts on the Google-owned YouTube every month.
European leaders are gearing up for the possibility of a sudden America-shaped hole in the Ukraine defense budget.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Last Tuesday, content conglomerate Thomson Reuters notched a big legal win against AI firm ROSS. Is it a sign of what’s to come?
De Beers, one of the largest companies in the diamond mining sector, has been battered by the ascendance of cheaper lab-grown gems.
Walmart said Thursday that it made a record $681 billion in sales, and yet its shares had their worst day in three years, tumbling 6.5%.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
There are signs that the emissions-free long haul semi-truck industry is slowly but surely picking up momentum, with or without Nikola.
The sector has been soaring on an atomic tailwind thanks to the energy demands of AI-hungry tech companies.
The American people may have voted to Make America Healthy Again at the ballot box. But how are they voting with their wallets?
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.